Corona brewer to invest nearly $200 million in Canadian marijuana grower, with plans to develop cannabis-infused drinks
The U.S. distributor of Corona beer is chasing a new type of buzz.
Constellation Brands Inc. has agreed to take a 9.9% stake in Canopy Growth Corp., a Canadian marijuana company, and plans to work with the grower to develop and market cannabis-infused beverages.
Canopy Growth is the world’s largest publicly traded cannabis company.
Constellation, a beer distributor that owns Corona, is reportedly planning to work with the grower to develop, market and sell cannabis-infused beverages.
The agreement, confirmed in a press release Monday, is $245 million Canadian dollars ($191 million) in exchange for a 9.9 percent stake in the Canopy Growth Corporation.
It is seen by Constellation Brands President and CEO, Rob Sands, as an anticipation of a nationwide legalization of marijuana in the United States.
"We think that it's highly likely, given what's happened at the state level," said Sands in an interview with the Wall Street Journal.
In 2018, California is set to legalize the cultivation and selling of recreational marijuana, but Sands said his company didn't plan to sell the product in the U.S. until marijuana was legal nationwide.
He added that Constellation would look to starting selling in countries where recreational marijuana is legal and Canada could be an option if, as scheduled, legislation there is relaxed next year.
Constellation Brands is a listed on the S&P 500 and posted record net sales of $7.3 billion for its fiscal 2017 results.
Canopy Growth is the world's largest publicly traded cannabis company, with a market valuation of 2.2 billion Canadian dollars. It is listed on the Toronto Stock Exchange.
Constellation said the transaction is expected to close during the Company's third quarter of fiscal 2018.